A detailed history of New Edge Advisors, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, New Edge Advisors, LLC holds 16,691 shares of BDX stock, worth $3.81 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
16,691
Previous 16,733 0.25%
Holding current value
$3.81 Million
Previous $3.91 Million 2.92%
% of portfolio
0.03%
Previous 0.03%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$221.47 - $242.41 $9,301 - $10,181
-42 Reduced 0.25%
16,691 $4.02 Million
Q2 2024

Aug 15, 2024

SELL
$225.07 - $246.17 $1.1 Million - $1.2 Million
-4,870 Reduced 22.54%
16,733 $3.91 Million
Q1 2024

May 14, 2024

BUY
$233.45 - $247.73 $518,025 - $549,712
2,219 Added 11.45%
21,603 $5.35 Million
Q4 2023

Feb 13, 2024

BUY
$232.24 - $267.23 $298,428 - $343,390
1,285 Added 7.1%
19,384 $4.73 Million
Q3 2023

Nov 14, 2023

BUY
$254.9 - $283.59 $359,409 - $399,861
1,410 Added 8.45%
18,099 $4.68 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $310,860 - $345,977
-1,304 Reduced 7.25%
16,689 $4.41 Million
Q1 2023

May 12, 2023

SELL
$229.71 - $259.35 $1.64 Million - $1.85 Million
-7,118 Reduced 28.35%
17,993 $4.45 Million
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $1.18 Million - $1.38 Million
5,387 Added 27.31%
25,111 $6.39 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $119,869 - $620,676
2,349 Added 13.52%
19,724 $4.4 Million
Q2 2022

Aug 09, 2022

SELL
$234.74 - $275.42 $931,448 - $1.09 Million
-3,968 Reduced 18.59%
17,375 $4.28 Million
Q1 2022

May 13, 2022

BUY
$243.64 - $270.48 $1.33 Million - $1.48 Million
5,479 Added 34.54%
21,343 $5.68 Million
Q4 2021

Feb 17, 2022

BUY
$230.08 - $250.94 $2.08 Million - $2.26 Million
9,022 Added 131.86%
15,864 $3.99 Million
Q3 2021

Oct 29, 2021

BUY
$232.72 - $256.47 $175,238 - $193,121
753 Added 12.37%
6,842 $1.68 Million
Q2 2021

Jul 22, 2021

SELL
$232.65 - $254.58 $39,783 - $43,533
-171 Reduced 2.73%
6,089 $1.48 Million
Q1 2021

Apr 26, 2021

SELL
$232.09 - $256.88 $1.44 Million - $1.59 Million
-6,191 Reduced 49.72%
6,260 $1.52 Million
Q4 2020

Jan 27, 2021

SELL
$221.92 - $245.94 $15.6 Million - $17.2 Million
-70,095 Reduced 84.92%
12,451 $3.12 Million
Q3 2020

Nov 03, 2020

SELL
$215.77 - $276.76 $13,809 - $17,712
-64 Reduced 0.08%
82,546 $19.2 Million
Q2 2020

Jul 29, 2020

BUY
$219.9 - $263.41 $2.5 Million - $2.99 Million
11,347 Added 15.92%
82,610 $19.8 Million
Q1 2020

May 04, 2020

BUY
$195.69 - $279.01 $980,015 - $1.4 Million
5,008 Added 7.56%
71,263 $16.4 Million
Q4 2019

Jan 31, 2020

BUY
$236.45 - $266.82 $1.14 Million - $1.29 Million
4,826 Added 7.86%
66,255 $18 Million
Q3 2019

Nov 06, 2019

BUY
$230.58 - $256.08 $1.77 Million - $1.97 Million
7,676 Added 14.28%
61,429 $15.6 Million
Q2 2019

Aug 05, 2019

BUY
$217.4 - $246.08 $319,360 - $361,491
1,469 Added 2.81%
53,753 $13.5 Million
Q1 2019

May 09, 2019

BUY
$206.05 - $248.17 $1.1 Million - $1.33 Million
5,347 Added 11.39%
52,284 $539,000
Q4 2018

Jan 29, 2019

BUY
$204.73 - $257.93 $206,982 - $260,767
1,011 Added 2.2%
46,937 $10.6 Million
Q3 2018

Oct 29, 2018

BUY
$233.07 - $256.0 $48,478 - $53,248
208 Added 0.45%
45,926 $12 Million
Q2 2018

Jul 19, 2018

BUY
$208.1 - $233.85 $133,600 - $150,131
642 Added 1.42%
45,718 $10.9 Million
Q1 2018

May 11, 2018

BUY
$205.46 - $240.27 $932,993 - $1.09 Million
4,541 Added 11.2%
45,076 $9.62 Million
Q4 2017

Feb 08, 2018

BUY
$189.0 - $222.64 $210,924 - $248,466
1,116 Added 2.83%
40,535 $8.97 Million
Q3 2017

Nov 13, 2017

BUY
$186.89 - $198.9 $438,630 - $466,818
2,347 Added 6.33%
39,419 $7.77 Million
Q2 2017

Aug 16, 2017

BUY
N/A
37,072
37,072 $0

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track New Edge Advisors, LLC Portfolio

Follow New Edge Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.